Get the Stockscreener App
7.03
6.35%
0.42
After Hours:
6.55
-0.48
-6.83%
Cumberland Pharmaceuticals Inc stock is traded at $7.03, with a volume of 72,339.
It is up +6.35% in the last 24 hours and up +4.15% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
See More
Previous Close:
$6.61
Open:
$6.47
24h Volume:
72,339
Relative Volume:
0.08
Market Cap:
$105.33M
Revenue:
$41.94M
Net Income/Loss:
$-7.40M
P/E Ratio:
-14.25
EPS:
-0.4935
Net Cash Flow:
$1.29M
1W Performance:
-3.70%
1M Performance:
+4.15%
6M Performance:
+87.97%
1Y Performance:
+100.00%
1-Day Range:
$6.31
$7.20
1-Week Range:
$5.75
$8.06
52-Week Range:
$1.85
$8.09
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
7.03 | 99.04M | 41.94M | -7.40M | 1.29M | -0.4935 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPIX|Cumberland Pharmaceuticals Inc|Price:7.030|Chg%:+0.420 - TradingKey
Cumberland Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:CPIX - TradingView
TradingKey - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc - TradingKey
CPIX|Cumberland Pharmaceuticals Inc|Price:6.610|Chg%:-0.375 - TradingKey
Cumberland Pharmaceuticals | 8-K: Current report - Moomoo
Cumberland Pharmaceuticals declares $1.50 dividend - MSN
Cumberland Pharma Board of Directors Has Authorized and Declared a Special Cash Div of $1.50 a Shr >CPIX - Moomoo
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? - The Globe and Mail
BRIEF-Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - Dailyhunt
Cumberland Pharmaceuticals 8-K Filing July 2026: Key Company Details, Stock Info, and Address on NASDAQ CPIX - Minichart
Cumberland Pharmaceuticals Announces Special Dividend, Share Buyback - TipRanks
Cumberland Pharmaceuticals declares $1.50 special dividend, $5M buyback after $100M Apotex deal - TradingView
Cumberland Pharmaceuticals (Nasdaq: CPIX) returns cash after $100M Apotex deal - Stock Titan
Cumberland Pharmaceuticals Inc. (CPIX) Stock: Unveils Special Dividend While Advancing Ifetroban Rare Disease Pipeline - parameter.io
Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 - marketscreener.com
Press Release: CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - Moomoo
/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./ - Yahoo Finance
Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share - TradingView
CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE - TradingView
Cumberland Pharmaceuticals (CPIX) Sees Modest Decline, Tests Key Support ZonePercent Above MA - dars.gov.et
Cumberland outlines new product expansion and sees $8.3M Q3 revenues while advancing clinical pipeline - MSN
Cumberland Pharmaceuticals (CPIX) Plunges Over 10% as Selling Pressure IntensifiesTriangle Correction - dars.gov.et
Cumberland Pharmaceuticals (CPIX) Slides 11.6%: Testing Key Support Near $5.98Quote Data - DonanımHaber
Cumberland Pharmaceuticals Sells Branded Drug Portfolio to Apotex for $100M, Refocuses on Rare Disease Pipeline 1 - Minichart
CPIXCumberland Pharmaceuticals Inc Latest SEC Filings - Finviz
Cumberland Refocuses on Rare Disease Pipeline After Asset Sale - TipRanks
Cumberland (CPIX) nets $100M from Apotex deal, shifts to rare disease pipeline - Stock Titan
Cumberland Pharmaceuticals closes $100 million sale of drug portfolio - The Business Journals
Cumberland sells branded drug portfolio to Apotex for $100m By Investing.com - Investing.com South Africa
Cumberland sells branded drug portfolio to Apotex for $100m - Investing.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - The Globe and Mail
Cumberland Pharmaceuticals (CPIX) Slips 3.65% — Testing Key Support Near $6.26Overvalued Signals - dars.gov.et
Cumberland Pharma advances Duchenne program with new safety, efficacy data - MSN
Cumberland Pharma Advances Duchenne Program With New Safety, Efficacy Data - Sahm
Cumberland shares updated trial results for DMD heart therapy - Investing.com UK
Why Is Cumberland Pharma Stock Gaining Friday?Cumberland Pharma (NASDAQ:CPIX) - Benzinga
Cumberland says updated DMD heart data strengthen ifetroban case - Stock Titan
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference - Yahoo Finance
Cumberland Pharmaceuticals Inc (CPIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Shareholders back Cumberland (NASDAQ: CPIX) sale of most assets - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Institutional Confidence - TradingKey
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement - Sahm
RedHill closes $6M financing, with up to $13.4M more possible - Stock Titan
Cumberland Pharmaceuticals Inc (CPIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RedHill Biopharma raises $6M now, with $13.4M more tied to warrants - Stock Titan
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
2.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):